Annotation Detail

Information
Associated Genes
PTEN
Associated Variants
PTEN DELETION ( ENST00000371953.8 )
PTEN DELETION ( ENST00000371953.8 )
Associated Disease
pancreatic carcinoma
Source Database
CIViC Evidence
Description
Among 33 patients treated with pan-AKT inhibitor MK-2206 in this phase 1 study, one patient with pancreatic adenocarcinoma and PTEN loss/KRAS G12D mutation experienced a decrease of approximately 60% in cancer antigen 19-9 levels and 23% shrinkage in tumor measurements.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/938
Gene URL
https://civic.genome.wustl.edu/links/genes/41
Variant URL
https://civic.genome.wustl.edu/links/variants/214
Rating
2
Evidence Type
Predictive
Disease
Pancreatic Carcinoma
Evidence Direction
Supports
Drug
Akt Inhibitor MK2206
Evidence Level
C
Clinical Significance
Sensitivity/Response
Pubmed
22025163
Drugs
Drug NameSensitivitySupported
Akt Inhibitor MK2206Sensitivitytrue